艾媒报告|2020年1-2月中国母婴行业运行状况及企业商情动态月度报告

本报告研究涉及企业/品牌/案例：爹地宝贝，帮宝适，巴拉巴拉；其他提及企业/品牌：掌通家园，智慧树，宝宝巴士，小伴龙，妈妈网孕育，宝宝树孕育，柚宝宝孕育，亲宝宝，妈妈网轻聊，小豆苗疫苗助手，宝宝知道，辣妈帮，妈妈帮，孕期伴侣

2020年1-2月中国母婴产品线上交易较往年增多。艾媒咨询分析师认为，疫情出门受限期间，手机App成为了丰富用户业余生活的重要工具，母婴垂直线类平台或获得发展机遇，迎来上升期。

During the epidemic, the top three most downloaded APP types among mother groups were news, maternal and child vertical, and social. In January 2020, the mother-and-baby app with the largest monthly active population was conceived by Maoma.com, with a total of 17,514,400 people, an increase of 2.47% from the previous month.

艾媒报告 |2019年中国生物医药产业发展及舆论焦点分析报告

本报告研究涉及企业/品牌包括:Takeda、GSK、Sanofi、Celgene、Novartis、宝洁、CVC Fund VII、Shire、诺华OTC、Bioverativ、Juno Therapeutics、AveXis、Impact Biomedicines、Tesaro、Ablynx、默克OTC、Recordati控股公司FIMEI、复星医药、海正药业、康弘药业、泰合健康、齐鲁制药、复宏汉霖、信达生物、张江生物、恒瑞医药、三生国健、嘉和生物、百奥泰、深圳龙瑞、天坛生物、华兰生物、博雅生物、上海莱士、卫光生物、辽宁成大、智飞生物、康泰生物、沃森生物、利德曼、交大昂立、华润双鹤、力生制药、海欣股份、联环药业、白云山、中源协和、普洛药业

随着生物医药技术不断突破，中国生物医药产业快速发展，2018年，单抗、血液制品、疫苗等生物医药相关领域多家头部上市企业营收均超亿元，实现同比增长。iiMedia Research(艾媒咨询)监测发现，生物医药产业网络言值指数为49.7，网民评价态度偏向正面，上海网民对生物医药产业的关注度最高。未来，随着中国生物医药行业上市公司数量增多，行业与企业间竞争将更加激烈。

The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry.

艾媒舆情 | 2018中国重大社会事件舆情监测分析报告之疫苗事件

2018年7月，长春长生生物科技有限公司的冻干人用狂犬病疫苗及百白破联合疫苗接连出现问题，深入探究发现，该公司还存在一年内接连收到多次行政处罚，企业销售投入过高引出背后贪腐案，公司主要董事会成员私有化资产运作等问题，全民哗然。习总书记、国务院总理对事件作出重要指示，多个中央及地方部门纷纷立案侦查，表示将严惩相关责任人。艾媒舆情（yq.iimedia.cn）就此事进行舆情监测。